The Cassandra Protocol
S01E12 : TELOMERE CLIFF 3/3 : UNITY BIOTECHNOLOGY
The servers hum in the Sedona heat. We recover the corrupted audio artifact of a $700M lie. The margin call on the human body has arrived. Listen closely.
Telomere Cliff
Unity Biotechnology
AUDIT: Unity Biotechnology: Auditing Metabolic Bankruptcy and Senolytic Insolvency
Audit the $700M collapse of Unity Biotech. Explore the clinical failure of senolytics, SASP, and how metabolic bankruptcy led to DGCL 275 dissolution.
Zombie Cells
NOTES: Unity Biotechnology: The Cellular Margin Call
Unity Biotech promised to cure aging but burned $700M on a zombie cell hustle. A cynical dive into the Telomere Cliff and rotting from the inside out.
Cassandra Protocol
S01E07: TELOMERE CLIFF 2/3: ALTOS LABS
The Cassandra Protocol is active. Thermodynamic entropy does not accept venture capital. Uncover the dark reality of Altos Labs and our biological debt.
sector-health
NOTES: The Three-Billion-Dollar Banana Stand at the End of the World
Altos Labs is a $3 billion banana stand at the end of the world. Why billionaire tech bros are funding a terrifying, tumor-filled teratoma tightrope act.
Altos Labs
AUDIT: Altos Labs: Senolytic Insolvency, and the $3 Billion Biological Debt
A forensic audit of Altos Labs' $3B longevity pivot. Explore the biological reality of epigenetic reprogramming, senolytic insolvency, and FDA roadblocks.
Cassandra Protocol
S01E03: TELOMERE CLIFF 1/3: BIOAGE LABS
The Cassandra Protocol is active. BioAge sells a payday loan for the human chassis while the biological ledger collects. What wakes you when the fire hits?
BioAge Labs
AUDIT: BioAge Labs
BioAge Labs' $115M pivot to NLRP3 inhibitor BGE-102 masks the biological debt of aging. An audit of the STRIDES trial failure and GLP-1 sarcopenic tax.
Biological Payday Loan
NOTES: A Payday Loan for Your Rotting Cellular Infrastructure
BioAge's $115M offering isn't a cure; it's a payday loan against rotting cells. They aren't stopping aging, just cutting the wire to your biological alarm.